WEZEL PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
WEZEL PHARMA
Largest movements
- Cash +€43,546
up €43,546 (+36.8%), from €118,481 to €162,027
mainly Net result for the year (+€52,338) and Trade debts (+€25,608)
- Tangible fixed assets -€10,094
down €10,094 (-20.5%), from €49,238 to €39,145
of which Plant, machinery and equipment: -€9,537
- Intangible fixed assets -€6,500
down €6,500 (-26.7%), from €24,362 to €17,862
- Stocks and contracts +€6,042
up €6,042 (+4.1%), from €149,147 to €155,189
- Current portion of long-term debt -€59,524
no longer reported in 2025 (was €59,524)
- Reserves +€52,338
up €52,338 (+21.4%), from €244,452 to €296,790
- Trade debts +€25,608
up €25,608 (+17.8%), from €143,872 to €169,480
- Tax, wage and social debts +€9,488
up €9,488 (+44.1%), from €21,529 to €31,017
of which Taxes: +€9,848
- Gross operating margin +€49,831
up €49,831 (+21.9%), from €227,657 to €277,488
- Staff costs +€13,538
up €13,538 (+7.8%), from €173,938 to €187,476
- Taxes +€10,149
up €10,149 (+110.0%), from €9,224 to €19,373
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €490,375 | €520,638 | +€30,263 | +6.2% |
| Fixed assets | 21/28 | €75,151 | €58,557 | -€16,594 | -22.1% |
| Intangible fixed assets | 21 | €24,362 | €17,862 | -€6,500 | -26.7% |
| Tangible fixed assets | 22/27 | €49,238 | €39,145 | -€10,094 | -20.5% |
| Plant, machinery and equipment | 23 | €48,405 | €38,868 | -€9,537 | -19.7% |
| Furniture and vehicles | 24 | €833 | €277 | -€556 | -66.8% |
| Financial fixed assets | 28 | €1,551 | €1,551 | = | 0.0% |
| Current assets | 29/58 | €415,224 | €462,081 | +€46,856 | +11.3% |
| Stocks and contracts in progress | 3 | €149,147 | €155,189 | +€6,042 | +4.1% |
| Stocks | 30/36 | €149,147 | €155,189 | +€6,042 | +4.1% |
| Amounts receivable within one year | 40/41 | €147,596 | €144,864 | -€2,732 | -1.9% |
| Trade receivables | 40 | €144,769 | €144,089 | -€680 | -0.5% |
| Other amounts receivable | 41 | €2,827 | €776 | -€2,051 | -72.6% |
| Cash at bank and in hand | 54/58 | €118,481 | €162,027 | +€43,546 | +36.8% |
| Total equity and liabilities | 10/49 | €490,375 | €520,638 | +€30,263 | +6.2% |
| Equity | 10/15 | €256,952 | €309,290 | +€52,338 | +20.4% |
| Contributions | 10/11 | €12,500 | €12,500 | = | 0.0% |
| Reserves | 13 | €244,452 | €296,790 | +€52,338 | +21.4% |
| Distributable reserves | 133 | €244,452 | €296,790 | +€52,338 | +21.4% |
| Amounts payable | 17/49 | €233,423 | €211,348 | -€22,075 | -9.5% |
| Amounts payable within one year | 42/48 | €233,423 | €211,348 | -€22,075 | -9.5% |
| Current portion of amounts payable after more than one year | 42 | €59,524 | - | -€59,524 | |
| Trade debts | 44 | €143,872 | €169,480 | +€25,608 | +17.8% |
| Suppliers | 440/4 | €143,872 | €169,480 | +€25,608 | +17.8% |
| Taxes, remuneration and social security | 45 | €21,529 | €31,017 | +€9,488 | +44.1% |
| Taxes | 450/3 | - | €9,848 | +€9,848 | |
| Remuneration and social security | 454/9 | €21,529 | €21,170 | -€359 | -1.7% |
| Other amounts payable | 47/48 | €8,499 | €10,851 | +€2,352 | +27.7% |
| Remuneration, social security and pensions | 62 | €173,938 | €187,476 | +€13,538 | +7.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €16,920 | €16,594 | -€326 | -1.9% |
| Other operating charges | 640/8 | €733 | €459 | -€274 | -37.4% |
| Gross operating margin | 9900 | €227,657 | €277,488 | +€49,831 | +21.9% |
| Operating profit (loss) | 9901 | €36,066 | €72,960 | +€36,894 | +102.3% |
| Financial income | 75/76B | €2,142 | €1,773 | -€368 | -17.2% |
| Recurring financial income | 75 | €2,142 | €1,773 | -€368 | -17.2% |
| Financial charges | 65/66B | €5,439 | €3,022 | -€2,418 | -44.4% |
| Recurring financial charges | 65 | €5,439 | €3,022 | -€2,418 | -44.4% |
| Profit (loss) for the period before taxes | 9903 | €32,768 | €71,712 | +€38,943 | +118.8% |
| Income taxes | 67/77 | €9,224 | €19,373 | +€10,149 | +110.0% |
| Profit (loss) for the period | 9904 | €23,544 | €52,338 | +€28,794 | +122.3% |
| Profit (loss) for the period to be appropriated | 9905 | €23,544 | €52,338 | +€28,794 | +122.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.